The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Estimated Market Size Of The Lentiviral Vector Market During 2026–2030?
The lentiviral vector market size has experienced significant expansion in recent years. It is anticipated to increase from $16.48 billion in 2025 to $18.95 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.0%. This historical growth can be attributed to the advancement of stable lentiviral production methods, a rising prevalence of genetic disorders, an upsurge in academic and clinical research, increased investments in gene therapy R&D, and the accessibility of transduction and packaging kits.
The lentiviral vector market is anticipated to experience significant expansion in the coming years. This market is projected to reach $30.66 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.8%. Factors contributing to this growth during the forecast period include the expanding development of gene therapies, the implementation of automated vector manufacturing systems, partnerships between biotechnology and pharmaceutical firms, the emergence of new applications for lentiviral vectors, and increasing demand from developing economies. Key trends expected over the forecast period encompass a rise in gene therapy adoption, progress in viral vector engineering, faster regulatory compliance and approvals, greater research investment for genetic disorders, and an increase in contract manufacturing capacity.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14742&type=smp
What Underlying Factors Are Accelerating The Growth Of The Lentiviral Vector Market?
The expanding occurrence of chronic illnesses is projected to drive growth in the lentiviral vectors market in the future. These conditions are defined as long-lasting medical ailments that generally advance gradually and frequently endure for years or a lifetime. The rise in chronic disease prevalence is attributed to factors such as an aging demographic, poor lifestyle choices, urban development, and environmental influences. Lentiviral vectors provide adaptable and effective instruments for creating vaccines and therapeutic approaches for chronic diseases, thereby addressing unfulfilled medical requirements and enhancing patient results. For example, in September 2024, data from the British Heart Foundation, a cardiovascular research charity based in the UK, indicated that in the UK, roughly 7.6 million individuals suffer from heart and circulatory diseases, with approximately 4 million males and 3.6 million females affected. These illnesses account for about 27% of all fatalities in the UK, amounting to more than 170,000 deaths per year, or around 480 daily deaths, which means one death occurs every three minutes. Consequently, the growing incidence of chronic diseases is fueling the expansion of the lentiviral vectors market.
How Are The Various Segments Of The Lentiviral Vector Market Categorized?
The lentiviral vector market covered in this report is segmented –
1) By Product Type: Kits, Reagents And Consumables
2) By Indication: Cancer, Genetic Disorder, Infectious Disease, Veterinary Disease, Other Indications
3) By End User: Biotechnology Companies, Pharmaceutical Companies, Contract Research Organization (CRO), Academic And Research Institutes
Subsegments:
1) By Kits: Lentiviral Transduction Kits, Lentiviral Packaging Kits, Lentiviral Vector Production Kits
2) By Reagents and Consumables: Lentiviral Packaging Reagents, Lentiviral Vector Concentration Reagents, Transfection Reagents for Lentiviral Vectors
What Trends Are Affecting The Expansion Of The Lentiviral Vector Market?
Major companies operating in the lentiviral vectors market are prioritizing the development of LV vector production platforms, such as LentiSure, to enhance the efficacy and resilience of generating lentivirus vectors for cell-based immuno-oncology therapies. LentiSure serves as an LV vector production platform for lentiviral vectors employed in cell-based immuno-oncology therapies, specifically engineered to boost efficiency and robustness in vector creation. For example, in May 2023, Yposkesi sk pharmteco, a viral vectors manufacturer based in France, unveiled LentiSure, an advanced platform designed to optimize the production of lentiviral (LV) vectors, aiming to improve the consistency and efficiency of lentivirus manufacturing. This platform addresses the escalating requirement for reliable and economically scalable viral-vector manufacturing technologies within cell and gene therapies. It delivers consistent product quality with average titers at cell culture harvest reaching 10e7 IG/mL bioreactor volume, ensuring elevated productivity and success for cell therapy innovators.
Which Major Firms Influence Developments In The Lentiviral Vector Market?
Major companies operating in the lentiviral vector market are Thermo Fisher Scientific Inc., Lonza Group AG, Cytiva, Takara Bio Inc., Promega Corporation, Bio-Rad Laboratories Inc., Merck KGaA, Agilent Technologies Inc., Oxford Biomedica, Sirion-Biotech GmbH, Yposkesi, Applied Biological Materials Inc., OriGene Technologies Inc., Sino Biological Inc., Charles River Laboratories, Vigene Biosciences, VectorBuilder, Cell Biolabs Inc., Addgene, GeneCopoeia Inc.
Read the full lentiviral vector market report here:
https://www.thebusinessresearchcompany.com/report/lentiviral-vector-global-market-report
Which Region Is Projected To Dominate The Lentiviral Vector Market During The Forecast Period?
North America was the largest region in the lentiviral vector market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lentiviral vector market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Lentiviral Vector Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=14742&type=smp
Browse Through More Reports Similar to the Global Lentiviral Vector Market 2026, By The Business Research Company
Lentiviral Vector Market Report 2026
https://www.thebusinessresearchcompany.com/report/lentiviral-vector-global-market-report
Oral Expectorant Market Report 2026
https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report
Vector Control Market Report 2026
https://www.thebusinessresearchcompany.com/report/vector-control-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model